Skip to main content
Clinical Trials/NCT04648488
NCT04648488UnknownNot Applicable

Early Mobilisation After Surgery in Patients With Elbow Fracture-dislocation - a Randomised Clinical Trial

Region Östergötland0 sites60 target enrollmentStarted: January 1, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
60
Primary Endpoint
Oxford elbow score (OES 0-48 Points)

Study Overview

Brief Summary

The purpose with the study is to evalute if early mobilsation after surgery in patients vid elbow frakture-dislocation may lead to better armfunction and reduce common complications as stiffnes in the elbow. After surgery patients will be randomised to either early mobilisation (exercise treatment 3 Days after surgery) or ordinary treatment (plaster and exercise treatment 3 weeks after surgery).

Detailed Description

In patients with elbow fracture in combinations with dislocation, surgery is often indicated. After surgery the ordinary standard praxis treatment is immobilisation in a plaster for 3 weeks. One common complication is "stiff elbow". Stiffness in the elbow may be due to "heterotopic ossification" which is the abnormal growth of bone in the non-skeletal tissues including muscles or tendons. There is a prospective study that have reported positive results with early mobilisation starting two days after surgery in these patients. However, randomised clinical trials are missing. Therefore our aim was to investigate if early mobilisation may increase elbow function (increased range of motion and decreased pain) and also reduce comlications as stiff elbow compared to ordinary treatment in these patients.

All patients operated with elbow fracture-dislocation at the University hospital in Linköping were asked if the wanted to participate in the study. They had thourough written and oral information about the study. If they agree to participate written informed consent was collected. After surgery patients were randomised to either early mobilisation or to ordinary treatment (standard praxis).

At baseline before surgery or directly after patients filled in some background vatiables such as gender, age social status medical treatment etc They also filled in some self-adminstrated outcome measure in purpuse to evalute upper extremity function and activity and health related quality of Life.

Follow ups with X ray and upper extremity function and activity were at 3 weeks 3 and 12 months with an independent observer.

In beteween these follow ups patient followed the treatment regime (ordinary or early exrecise treatment) and had support from a physiotherapist.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients over 18 years with elbow fracture-dislocation being operated on.

Exclusion Criteria

  • •ongoing cancer and earlier radiation therapy in the study arm
  • •neurological disease
  • •cervcialgia or disc herniation in the neck
  • •associated nerv or blodvessel injury

Arms & Interventions

Early mobilisation

Experimental

Patients will start unloaded exercise treatment 3 days after surgery. They will remove the plaster 5 times every day to perform range of motion exercises.

Intervention: Experimental early mobilisation (Other)

Standard treatment

Active Comparator

Patients will have a plaster 3 weeks after surgery and after that start with exercise treatment.

Intervention: Aktive comparator standrad treatmnet (Other)

Outcomes

Primary Outcomes

Oxford elbow score (OES 0-48 Points)

Time Frame: 12 month follow up

Evaluating pain, elbowfunction and psychological status

Secondary Outcomes

  • Patient Global impression of change(at three and 12 months)
  • Re-operation(in between 3 and 12 month follow up)
  • Range of motion(12 month follow up)
  • Heterotopic ossification(3 month follow up)
  • upper extremity activity scale (0-8)(12 month follow up)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Teresa Holmgren

PhD Registered physiotherapist

Region Östergötland

Similar Trials